Shree Ganesh Remedies

Shree Ganesh Remedies

527.00
+13.10
(2.55%)
Market Cap
659.70 Cr
EPS
17.96
PE Ratio
30.84
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
950.00
52 Week Low
494.95
PB Ratio
4.65
Debt to Equity
0.28
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
positive
Shree Ganesh Remedies Limited's Board of Directors appointed Ms. Shruti Sohane as Additional Director (Non-Executive, Independent) for a five-year term effective August 08, 2025, subject to shareholder approval. Ms. Sohane is a qualified Company Secretary with over a decade of experience in corporate governance and legal compliance, and is a member of the Institute of Company Secretaries of India since 2014. The company also reappointed M/s. M. I. Prajapati & Associates as Cost Auditor for 2025-2026 at a remuneration of Rs. 55,000 plus applicable taxes. Additionally, the Board appointed Mr. Vishal Thawani as Scrutinizer for the e-voting process at the 30th Annual General Meeting and approved the Notice for the AGM along with the Directors Report for the year ended March 31, 2025.
neutral
Shree Ganesh Remedies Reports Q1 FY2026 Financial Results with Profit GrowthAug 01, 2025
Shree Ganesh Remedies Limited's Board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. The company reported consolidated revenue from operations of ₹2,466.79 lakhs compared to ₹2,477.99 lakhs in the same quarter last year. Profit after tax increased to ₹344.51 lakhs from ₹464.88 lakhs in the previous year quarter. Basic earnings per share stood at ₹2.68 compared to ₹3.62 in the corresponding quarter. On standalone basis, the company achieved profit after tax of ₹344.94 lakhs with basic EPS of ₹2.69. The company operates primarily in bulk drug intermediates business and has a wholly owned subsidiary SGRL USA INC. Total comprehensive income for the quarter was ₹344.16 lakhs on consolidated basis.
negative
Shree Ganesh Remedies Limited received a GST summons from the Superintendent of Central GST and Central Excise Unit, Vadodara, alleging violations related to expired stock found at a company warehouse that requires re-testing date updates. The summons involves a potential GST liability of approximately Rs. 88.61 Lacs. The company received the summons on July 18, 2025, and was required to appear before authorities on July 21, 2025. The company, supported by legal and tax counsel, believes the claims are untenable under existing law and judicial precedents, and plans to file an appeal before the appellate authority. The investigation is currently at a preliminary stage.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,636.20
#1 3,82,526.00
34.22
#1 54,729.00
9.71
#1 10,980
-19.84
43.29
5,710.00
1,51,038.30
65.74
9,712.00
18.67
2,191
26.74
28.97
3,567.10
1,21,948.70
59.71
11,539.40
6.99
1,911
19.91
51.91
1,513.00
1,21,429.70
22.68
28,409.50
7.12
5,291
9.88
39.80
1,244.70
1,02,131.70
#1 18.31
33,741.20
16.73
5,725
1.26
34.86
2,439.60
1,00,535.60
53.25
12,744.20
#1 20.90
2,007
-18.14
34.79
991.15
98,802.10
21.41
23,511.00
18.55
4,615
2.60
40.31
1,981.30
87,299.50
24.47
22,909.50
13.74
3,306
#1 51.64
38.96
5,459.50
64,864.00
28.71
13,458.30
3.70
2,216
21.39
52.88
1,086.00
62,953.10
18.78
32,345.60
9.43
3,484
-10.24
49.39
Forecast
Actual
Growth Rate
Revenue Growth
-12.95 %
Net Income Growth
-17.79 %
Cash Flow Change
0.69 %
ROE
-30.97 %
ROCE
-25.41 %
EBITDA Margin (Avg.)
9.86 %

Quarterly Financial Results

Quarterly Financials
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
10
12
14
16
14
17
22
39
25
33
28
27
25
Expenses
8
7
10
10
10
13
15
20
17
21
17
15
17
EBITDA
2
5
4
5
4
5
7
18
9
12
11
12
8
Operating Profit %
12 %
36 %
24 %
33 %
24 %
26 %
27 %
45 %
33 %
35 %
37 %
40 %
30 %
Depreciation
1
1
0
1
1
1
1
2
2
2
3
2
2
Interest
0
0
0
0
0
0
0
0
0
0
0
1
1
Profit Before Tax
1
4
4
4
3
4
6
16
6
9
8
9
5
Tax
1
1
1
1
1
1
1
4
2
2
2
2
1
Net Profit
1
3
3
3
2
3
4
13
5
6
5
7
4
EPS in ₹
0.85
6.18
2.31
3.03
4.68
3.02
3.50
10.01
3.62
4.97
4.22
5.13
2.68

Balance Sheet

Balance Sheet
2019
2020
2024
2025
Total Assets
41
55
171
192
Fixed Assets
15
20
81
95
Current Assets
26
34
70
78
Capital Work in Progress
0
0
17
9
Investments
4
3
5
18
Other Assets
23
32
69
70
Total Liabilities
41
55
171
192
Current Liabilities
7
10
19
16
Non Current Liabilities
1
3
30
31
Total Equity
34
42
122
145
Reserve & Surplus
25
33
109
132
Share Capital
9
9
13
13

Cash Flow

Cash Flow
2019
2020
2024
2025
Net Cash Flow
-6
1
7
-6
Investing Activities
-0
-3
-33
-36
Operating Activities
-5
5
31
31
Financing Activities
-0
-1
10
-1

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Feb 2023
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
68.39 %
68.39 %
69.12 %
69.12 %
69.12 %
69.12 %
69.12 %
68.27 %
68.27 %
69.32 %
69.33 %
69.33 %
69.33 %
69.33 %
69.33 %
69.33 %
70.50 %
72.80 %
72.80 %
72.80 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
27.52 %
27.74 %
25.92 %
25.85 %
26.03 %
26.35 %
26.33 %
26.68 %
27.25 %
26.37 %
28.11 %
28.05 %
27.96 %
28.06 %
28.14 %
28.51 %
27.23 %
24.88 %
24.89 %
24.87 %
Others
4.09 %
3.87 %
4.96 %
5.03 %
4.85 %
4.53 %
4.54 %
5.05 %
4.48 %
4.31 %
2.56 %
2.62 %
2.71 %
2.60 %
2.53 %
2.15 %
2.26 %
2.32 %
2.31 %
2.32 %
No of Share Holders
2,450
3,397
4,814
5,828
5,741
5,745
5,465
5,843
6,472
6,771
6,747
6,407
7,330
7,518
7,049
7,186
8,508
8,695
8,978
9,166

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 1 1.25 1.5 1.75 0.5 0.3 0.5 0.00
Dividend Yield (%) 0.00 0.00 2.49 2.32 0.54 0.59 0.2 0.04 0.07 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Sept 2021 DIVIDEND Dividend
₹ 1.75 /share
08 Sept 2021 255.80 318.97
02 Nov 2021 BONUS Bonus
1:5
01 Nov 2021 336.47 382.07
16 Sept 2022 DIVIDEND Dividend
₹ 0.50 /share
15 Sept 2022 313.71 251.36
03 Feb 2023 RIGHTS Rights
7:100
03 Feb 2023 256.67 250.56
07 Sept 2023 DIVIDEND Dividend
₹ 0.50 /share
07 Sept 2023 288.45 440.60
30 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Sept 2024 866.60 822.25
29 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 Oct 2024 767.10 756.85
05 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Feb 2025 669.45 893.20
19 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2025 724.45 749.35
01 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
01 Aug 2025 588.25 568.55
09 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
09 Sept 2025 561.25 587.30

Announcements

Closure of Trading Window6 days ago
Announcement under Regulation 30 (LODR)-Resignation of DirectorSep 15, 2025
Board Meeting Outcome for Outcome Of Board MeetingSep 15, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 09, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 09, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 19, 2025
Notice Of 30Th Annual General Meeting On September 09 2025Aug 18, 2025
Reg. 34 (1) Annual Report.Aug 18, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 08, 2025
Board Meeting Outcome for Outcome Of Board MeetingAug 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 02, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 02, 2025
Board Meeting Outcome for Outcome Of Board MeetingAug 01, 2025
Board Meeting Intimation for Unaudited (Standalone And Consolidated) Financial Results Of The Company For The Quarter Ended On June 30 2025Jul 28, 2025
Announcement Under Regulation 30 Of SEBI Listing Regulations Jul 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Closure of Trading WindowJun 26, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 21, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 19, 2025
Appointment Of Secretarial Auditors And Internal Auditors Of The CompanyMay 19, 2025
Financial Results March 31 2025May 19, 2025
Board Meeting Outcome for Outcome Of Board MeetingMay 19, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Resignation Of Secretarial Auditor.May 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 15, 2025
Board Meeting Intimation for The Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Financial Year Ended On March 31 2025May 10, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 26, 2025
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 26, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Closure of Trading WindowMar 25, 2025
Commissioning Of 2.5 MW Solar Power Project Mar 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 05, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 05, 2025
Statement Of Utilization Of The Proceeds Of The Rights Issue Of The Company.Feb 05, 2025
Integrated Filing (Financial)Feb 05, 2025
Results - Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 05, 2025
Board Meeting Outcome for Outcome Of Board MeetingFeb 05, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 30, 2025
Board Meeting Intimation for The Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 29, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Disclosure Under Regulation 29 (2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011.Dec 10, 2024
Disclosure Under Regulation 29 (2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011.Dec 03, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 12, 2024

Technical Indicators

RSI(14)
Neutral
39.97
ATR(14)
Less Volatile
25.75
STOCH(9,6)
Neutral
24.81
STOCH RSI(14)
Neutral
31.47
MACD(12,26)
Bearish
-3.99
ADX(14)
Strong Trend
32.74
UO(9)
Bearish
34.18
ROC(12)
Downtrend And Accelerating
-3.92
WillR(14)
Neutral
-63.45